Evidence supporting the use of: Resveratrol
For the health condition: Autoimmune Disorders

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Resveratrol is a natural polyphenol found in grapes, berries, and peanuts, widely studied for its antioxidant and anti-inflammatory properties. In the context of autoimmune disorders, there is preliminary scientific evidence suggesting that resveratrol may have beneficial effects, primarily based on in vitro studies and animal models. These studies indicate that resveratrol can modulate immune responses by inhibiting key inflammatory pathways such as NF-κB and suppressing the production of pro-inflammatory cytokines (e.g., TNF-α, IL-6). For example, research on models of rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus has shown resveratrol may reduce inflammation and disease severity by influencing T cell differentiation and reducing oxidative stress.

However, clinical evidence in humans is limited. Only a few small-scale clinical trials have investigated resveratrol in autoimmune diseases, and the results are inconclusive or preliminary. Most human studies focus on its general anti-inflammatory effects rather than direct disease modification in autoimmune conditions. Therefore, while there is a scientific rationale based on animal and cellular studies, there is not yet robust, high-quality evidence from large human trials to support the routine use of resveratrol for treating or managing autoimmune disorders.

In summary, resveratrol’s use for autoimmune disorders is supported by emerging preclinical data, but more research—especially well-designed clinical trials—is required to confirm efficacy and safety in humans.

More about resveratrol
More about Autoimmune Disorders